Synthesis, crystal structure analysis, photophysical, nonlinear optical properties, DFT, and docking studies of (2E,4E)-5-(4-methoxyphenyl)-1-(thiophen-2-yl)penta-2,4-dien-1-one as a potential SARS-CoV-2 inhibitor
摘要
In this study, the synthesis, single-crystal X-ray analysis, photophysical properties, DFT, and docking studies of a chalcone analog (2E,4E)-5-(4-methoxyphenyl)-1-(thiophen-2-yl) penta-2,4-dien-1-one (MPT) are reported. The synthesis of the title compound was achieved by the conventional Claisen–Schmidt reaction. The identity of the title compound was confirmed by spectroscopic techniques, and by X-ray diffraction analysis of single crystals. In the solid state, the molecule exhibits weak π–π interactions. The fluorescence spectrum of the title compound in the solid state shows a broad emission with a λmax at 517 nm and a significant Stokes shift of 142 nm. Using the Z-scan technique the third-order nonlinear optical properties of MPT were explored. The compound displayed a two-photon absorption (β = 2.36 × 10–6 cmW−1), nonlinear refraction (n2 = 2.37 × 10–10 cm2W−1), and a third-order nonlinear susceptibility (χ(3) = 3.84 × 10–8 esu). Theoretical calculations provided insights into structural properties, including the HOMO–LUMO energy gap. Molecular docking studies revealed that the synthesized compound showed the binding affinities of -11.1, -4.9, and -6.6 kcal/mol against the SARS-CoV-2 receptor (PDB ID: DZP). Furthermore, docking studies also suggest that the molecule may inhibit ORF8, a viral immunoglobulin-like (Ig-like) domain protein essential for SARS-CoV-2 binding, fusion, and entry into host cells.